Overview

A Study Investigating Interactions Between BMS-986322 and Rosuvastatin or Metformin in Healthy Participants

Status:
Not yet recruiting

Trial end date:
2023-01-30

Target enrollment:

Participant gender:

Summary

The aim of this study is to assess the effect of coadministration of multiple oral doses of BMS-986322 with rosuvastatin or metformin in healthy participants.

Phase:

Phase 1

Details

Lead Sponsor:

Bristol-Myers Squibb

Treatments:

Metformin
Rosuvastatin Calcium